
BMS-927711
CAS No. 1289023-67-1
BMS-927711( BMS-927711 )
Catalog No. M17925 CAS No. 1289023-67-1
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 88 | In Stock |
![]() ![]() |
10MG | 146 | In Stock |
![]() ![]() |
25MG | 300 | In Stock |
![]() ![]() |
50MG | 446 | In Stock |
![]() ![]() |
100MG | 647 | In Stock |
![]() ![]() |
500MG | 1341 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBMS-927711
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
-
DescriptionBMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-927711
-
PathwayOthers
-
TargetOther Targets
-
RecptorCGRP
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1289023-67-1
-
Formula Weight534.56
-
Molecular FormulaC28H28F2N6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 10 mg/mL 18.71 mM; Ethanol : 10 mg/mL 18.71 mM
-
SMILESFc1cccc(c1F)[C@@H]6CC[C@@H](OC(=O)N2CCC(CC2)N3c4cccnc4NC3=O)c5ncccc5[C@H]6N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
YM-750
YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A.
-
PI-55
PI-55 (6-(2-hydroxy-3-methylbenzylamino)purine) is a cytokinin receptor inhibitor that exhibits structural similarity to 6-benzylaminopurine (BAP).
-
Crocin (Gardenia Fru...
Crocin is a water-soluble carotenoid pigment of saffron (Crocus sativus L.). Crocin has anti-inflammatory anti-oxidative anti-apoptotic anti-asthma anti-cancer and hypolipidemic effects.